Evidence map›Paper›PMID 29324843›Full record

ArticlePLoS pathogens2018

Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice.

Daniele Viarisio, Karin Müller-Decker, Rosita Accardi, Alexis Robitaille, Matthias Dürst, Katrin Beer, Lars Jansen, Christa Flechtenmacher, Matthias Bozza, Richard Harbottle and 6 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Viruses · 2023
    Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Daniele ViarisioDeutsches Krebsforschungszentrum, Heidelberg, Germany.ORCID 0000-0002-3123-688X
Karin Müller-DeckerDeutsches Krebsforschungszentrum, Heidelberg, Germany.
Rosita AccardiInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Alexis RobitailleInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0002-9749-8276
Matthias DürstDepartment of Gynecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.ORCID 0000-0003-1235-1150
Katrin BeerDepartment of Gynecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.ORCID 0000-0003-0016-2117
Lars JansenDepartment of Gynecology, Jena University Hospital - Friedrich Schiller University, Jena, Germany.ORCID 0000-0002-2093-5861
Christa FlechtenmacherDepartment of Pathology, University Hospital of Heidelberg, Heidelberg, Germany.
Matthias BozzaDeutsches Krebsforschungszentrum, Heidelberg, Germany.
Richard HarbottleDeutsches Krebsforschungszentrum, Heidelberg, Germany.
Catherine VoegeleInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Maude ArdinInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Jiri ZavadilInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Sandra CaldeiraDeutsches Krebsforschungszentrum, Heidelberg, Germany.ORCID 0000-0002-6057-5979
Lutz GissmannDeutsches Krebsforschungszentrum, Heidelberg, Germany.
Massimo TommasinoInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0002-0890-8596
Centre international de recherche sur le cancer · FRGerman Cancer Research Center · DEJena University Hospital · DEHeidelberg University · DE

Funding

World Health Organization 001
6 · The paper itself

Abstract

Cutaneous beta human papillomavirus (HPV) types are suspected to be involved, together with ultraviolet (UV) radiation, in the development of non-melanoma skin cancer (NMSC). Studies in in vitro and in vivo experimental models have highlighted the transforming properties of beta HPV E6 and E7 oncoproteins. However, epidemiological findings indicate that beta HPV types may be required only at an initial stage of carcinogenesis, and may become dispensable after full establishment of NMSC. Here, we further investigate the potential role of beta HPVs in NMSC using a Cre-loxP-based transgenic (Tg) mouse model that expresses beta HPV38 E6 and E7 oncogenes in the basal layer of the skin epidermis and is highly susceptible to UV-induced carcinogenesis. Using whole-exome sequencing, we show that, in contrast to WT animals, when exposed to chronic UV irradiation K14 HPV38 E6/E7 Tg mice accumulate a large number of UV-induced DNA mutations, which increase proportionally with the severity of the skin lesions. The mutation pattern detected in the Tg skin lesions closely resembles that detected in human NMSC, with the highest mutation rate in p53 and Notch genes. Using the Cre-lox recombination system, we observed that deletion of the viral oncogenes after development of UV-induced skin lesions did not affect the tumour growth. Together, these findings support the concept that beta HPV types act only at an initial stage of carcinogenesis, by potentiating the deleterious effects of UV radiation.

Indexed as

AnimalsBetapapillomavirusCarcinogenesisEpidermisFemaleGene DeletionGenes, p53MiceMice, TransgenicMutagenesisMutationNeoplasm ProteinsNeoplasms, Radiation-InducedOncogene Proteins, ViralReceptors, NotchRecombinant ProteinsE6 protein, human papillomavirus type 38Neoplasm ProteinsOncogene Proteins, ViralReceptors, NotchRecombinant ProteinsViral Proteins

Identifiers

PMID29324843
PMCPMC5764406
OpenAlexW2783157165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.